Missense mutations in the multi-domain kinase LRRK2 cause late onset familial Parkinson's disease. They most commonly with classic proteinopathy in the form of Lewy bodies and Lewy neurites comprised of insoluble α-synuclein, but in rare cases can also manifest tauopathy. The normal function of LRRK2 has remained elusive, as have the cellular consequences of its mutation. Data from LRRK2 null model organisms and LRRK2-inhibitor treated animals support a physiological role for LRRK2 in regulating lysosome function. Since idiopathic and LRRK2-linked PD are associated with the intraneuronal accumulation of protein aggregates, a series of critical questions emerge. First, how do pathogenic mutations that increase LRRK2 kinase activity affect lysosome biology in neurons? Second, are mutation-induced changes in lysosome function sufficient to alter the metabolism of α-synuclein? Lastly, are changes caused by pathogenic mutation sensitive to reversal with LRRK2 kinase inhibitors? Here, we report that mutation of LRRK2 induces modest but significant changes in lysosomal morphology and acidification, and decreased basal autophagic flux when compared to WT neurons. These changes were associated with an accumulation of detergent-insoluble α-synuclein and increased neuronal release of α-synuclein and were reversed by pharmacologic inhibition of LRRK2 kinase activity. These data demonstrate a critical and disease-relevant influence of native neuronal LRRK2 kinase activity on lysosome function and α-synuclein homeostasis. Furthermore, they also suggest that lysosome dysfunction, altered neuronal α-synuclein metabolism, and the insidious accumulation of aggregated protein over decades may contribute to pathogenesis in this late-onset form of familial PD.
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Introduction
Parkinson's disease (PD) is an aging-associated neurodegenerative disorder characterized by insoluble proteinaceous Lewy body and Lewy neurite inclusions that accumulate within multiple affected neuronal populations. The primary component of these intracellular inclusions is α-synuclein (α-syn), a small aggregate-prone protein that plays a central role in both idiopathic and familial forms of PD. The broad role of this small protein on the majority of PD pathogenesis makes it critical that we understand how other PD-associated genetic insults influence α-syn homeostasis.
Mutations in leucine rich-repeat kinase 2 (LRRK2) are perhaps the most common genetic cause of PD, with the G2019S mutation being the most prevalent (Healy et al., 2008) . Pleomorphic pathology including tauopathy or pure nigral degeneration have been reported in rare cases (Bonifati, 2006; Zimprich et al., 2004) . However, these particular monogenic forms of disease most frequently match the pathology observed in sporadic PD with both late onset and neuronal Lewy body formation. LRRK2 is a rather unique protein in that it possesses two functional domains contributing kinase and GTPase activities, as well as numerous protein-binding motifs. The current consensus in the field is that the pathogenic mutations most likely share increased kinase activity as a common gain-of-function.
LRRK2 is implicated in the regulation of Wnt signaling (Berwick and Harvey, 2012; Sancho et al., 2009 ), synaptic transmission (Arranz et al., 2015 Matta et al., 2012) , mitochondrial function (Wang et al., 2012) , and cytoskeletal polymerization (Caesar et al., 2015; Caesar et al., 2013) . How these functions may contribute to the pathologic accumulation of PD-relevant proteins within neurons is unclear. Some of the earliest insights into LRRK2 neurobiology were gained from the 
